MapLight Therapeutics, Inc. (MPLT) Operating cash flow 2024–2025
MapLight Therapeutics, Inc. (MPLT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$138.1MFY2025 · since FY2024: -$78.8M → -$138.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$138.1M | -75.3% |
| FY2024 | -$78.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice